Last update :
19/11/2024
Beta-blocker   Esmolol hydrochloride  
injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Brevibloc Austria, Belgium, Canada, Denmark, Ecuador, Egypt, Finland, France, Germany, Great Britain, Greece, Hungary, Iran, Ireland, Italy, Mexico, New Zealand, Norway, Portugal, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, United States of America
Cardesmo India
Crevimol Mexico
Esmocard Belgium, Germany, India, Spain, Sweden
Esmolol Argentina, Chile, Iran, Switzerland, United States of America
Esocard India, Malaysia
Nevopax Mexico
Solmosol Mexico
Stability of mixtures   injection   Stability of mixtures : Esmolol hydrochloride     
Container Solvent Concentration Compound Temperature Storage Duration of stability References
Glass NaCl 0,9% or Glucose 5% 5 mg/ml
injection   Esmolol hydrochloride   
injection   Morphine sulfate 7,5 mg/ml
15°C-30°C
8 Hour
Light 8
Glass NaCl 0,9% or Glucose 5% 5 mg/ml
injection   Esmolol hydrochloride   
injection   Fentanyl citrate 25 µg/ml
15°C-30°C
8 Hour
Light 8
Not specified Glucose 5% 10 mg/ml
injection   Esmolol hydrochloride   
injection   Nitroprusside sodium 0,2 mg/ml
15-30°C
24 Hour
Protect from light 363
Level of evidence A+

  Mentions Légales